This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Enzon Pharmaceuticals Inc (ENZN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 11.67M 34.56M 6.52M 77.35M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 107.00K 478.00K 601.00K 1.90M
Total Current Assets 11.78M 35.04M 7.12M 198.64M
Property, Plant & Equipment, Gross 0.00 0.00 0.00 26.92M
Accumulated Depreciation & Depletion 0.00 0.00 0.00 25.78M
Property, Plant & Equipment, Net 0.00 0.00 0.00 1.14M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 11.11M 0.00 0.00 1.14M
Liabilities & Shareholder Equity
Total Assets 22.89M 35.04M 7.12M 199.78M
Accounts Payable 90.00K 181.00K 93.00K 776.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 190.00K 194.00K 0.00 0.00
Total Current Liabilities 4.80M 5.06M 1.31M 122.31M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 381.00K 558.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 381.00K 558.00K 0.00
Total Liabilities 4.80M 5.44M 1.87M 122.31M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 18.09M 29.60M 5.25M 77.47M
Common Par 441.00K 441.00K 441.00K 437.00K
Additional Paid In Capital 96.91M 130.06M 134.51M 224.80M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -79.27M -100.90M -129.70M -147.85M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 83.00K
Total Capitalization 18.09M 29.60M 5.25M 77.47M
Total Equity 18.09M 29.60M 5.25M 77.47M
Total Liabilities & Stock Equity 22.89M 35.04M 7.12M 199.78M
Total Common Shares Outstanding 44.21M 44.17M 44.09M 43.67M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 44.20M 44.12M 43.78M 46.73M
Diluted Weighted Shares Outstanding 44.22M 44.24M 51.05M 46.73M
Number of Employees 1 1 1 21
Number of Part-Time Employees 0 0 0 0
ENZN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ENZN Enzon Pharmaceuticals Inc

Chart of ENZN

Analysts Ratings for ENZN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ENZN ANALYST REPORT

ENZN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs